APO Research

APO RESEARCH · REPORT

Finasteride

Selected research

Industry Growth & Trends

Global Finasteride Industry Growth and Trends Forecast to 2032

Market perspective

The global Finasteride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Finasteride include Teva Pharmaceuticals, Sandoz, Shandong Renhetang Pharmaceutical, Merck, Zhejiang CONBA Pharmaceutical, Henan Topfond, Guangdong Eashu Pharmacetical, RelonChem and Dr. Reddy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Finasteride market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Finasteride market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Finasteride market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Finasteride.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Finasteride market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Finasteride Market by Company

Teva Pharmaceuticals

Sandoz

Shandong Renhetang Pharmaceutical

Merck

Zhejiang CONBA Pharmaceutical

Henan Topfond

Guangdong Eashu Pharmacetical

RelonChem

Dr. Reddy

Cipla

Actavis

Accord Pharmaceuticals

Finasteride Segment by Type

1mg Tablet

5mg Tablet

Finasteride Segment by Application

Medical Uses

Application 2

Finasteride Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Finasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Finasteride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Finasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1mg Tablet Table 2. Major Company of 5mg Tablet Table 3. Global Finasteride Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Finasteride Sales by Type (2021-2026) & (tons) Table 5. Global Finasteride Sales Market Share in Volume by Type (2021-2026) Table 6. Global Finasteride Sales by Type (2021-2026) & (US$ Million) Table 7. Global Finasteride Sales Market Share in Value by Type (2021-2026) Table 8. Global Finasteride Price by Type (2021-2026) & (US$/kg) Table 9. Global Finasteride Sales by Type (2027-2032) & (tons) Table 10. Global Finasteride Sales Market Share in Volume by Type (2027-2032) Table 11. Global Finasteride Sales by Type (2027-2032) & (US$ Million) Table 12. Global Finasteride Sales Market Share in Value by Type (2027-2032) Table 13. Global Finasteride Price by Type (2027-2032) & (US$/kg) Table 14. North America Finasteride Sales by Type (2021-2026) & (tons) Table 15. North America Finasteride Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Finasteride Sales by Type (2021-2026) & (tons) Table 17. Europe Finasteride Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Finasteride Sales by Type (2021-2026) & (tons) Table 19. Asia-Pacific Finasteride Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Finasteride Sales by Type (2021-2026) & (tons) Table 21. Latin America Finasteride Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Finasteride Sales by Type (2021-2026) & (tons) Table 23. Middle East and Africa Finasteride Sales by Type (2021-2026) & (US$ Million) Table 24. Finasteride Industry Trends Table 25. Finasteride Industry Drivers Table 26. Finasteride Industry Opportunities and Challenges Table 27. Finasteride Industry Restraints Table 28. Global Finasteride Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Finasteride Revenue Market Share by Company (2021-2026) Table 30. Global Finasteride Sales by Company (2021-2026) & (tons) Table 31. Global Finasteride Sales Share by Company (2021-2026) Table 32. Global Finasteride Market Price by Company (2021-2026) & (US$/kg) Table 33. Global Finasteride Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Finasteride Major Company Production Sites and Headquarters Table 35. Global Finasteride Company, Product Type & Application Table 36. Global Finasteride Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Finasteride by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Finasteride Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Finasteride Sales by Region (2021-2026) & (tons) Table 41. Global Finasteride Sales Market Share in Volume by Region (2021-2026) Table 42. Global Finasteride Sales by Region (2021-2026) & (US$ Million) Table 43. Global Finasteride Sales Market Share in Value by Region (2021-2026) Table 44. Global Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 45. Global Finasteride Sales by Region (2027-2032) & (tons) Table 46. Global Finasteride Sales Market Share in Volume by Region (2027-2032) Table 47. Global Finasteride Sales by Region (2027-2032) & (US$ Million) Table 48. Global Finasteride Sales Market Share in Value by Region (2027-2032) Table 49. Global Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 50. Global Finasteride Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Finasteride Sales by Application (2021-2026) & (tons) Table 52. Global Finasteride Sales Market Share in Volume by Application (2021-2026) Table 53. Global Finasteride Sales by Application (2021-2026) & (US$ Million) Table 54. Global Finasteride Sales Market Share in Value by Application (2021-2026) Table 55. Global Finasteride Price by Application (2021-2026) & (US$/kg) Table 56. Global Finasteride Sales by Application (2027-2032) & (tons) Table 57. Global Finasteride Sales Market Share in Volume by Application (2027-2032) Table 58. Global Finasteride Sales by Application (2027-2032) & (US$ Million) Table 59. Global Finasteride Sales Market Share in Value by Application (2027-2032) Table 60. Global Finasteride Price by Application (2027-2032) & (US$/kg) Table 61. North America Finasteride Sales by Application (2021-2026) & (tons) Table 62. North America Finasteride Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Finasteride Sales by Application (2021-2026) & (tons) Table 64. Europe Finasteride Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Finasteride Sales by Application (2021-2026) & (tons) Table 66. Asia-Pacific Finasteride Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Finasteride Sales by Application (2021-2026) & (tons) Table 68. Latin America Finasteride Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Finasteride Sales by Application (2021-2026) & (tons) Table 70. Middle East and Africa Finasteride Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Pharmaceuticals Company Information Table 72. Teva Pharmaceuticals Business Overview Table 73. Teva Pharmaceuticals Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Teva Pharmaceuticals Finasteride Product Portfolio Table 75. Teva Pharmaceuticals Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Sandoz Finasteride Product Portfolio Table 80. Sandoz Recent Development Table 81. Shandong Renhetang Pharmaceutical Company Information Table 82. Shandong Renhetang Pharmaceutical Business Overview Table 83. Shandong Renhetang Pharmaceutical Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Shandong Renhetang Pharmaceutical Finasteride Product Portfolio Table 85. Shandong Renhetang Pharmaceutical Recent Development Table 86. Merck Company Information Table 87. Merck Business Overview Table 88. Merck Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Merck Finasteride Product Portfolio Table 90. Merck Recent Development Table 91. Zhejiang CONBA Pharmaceutical Company Information Table 92. Zhejiang CONBA Pharmaceutical Business Overview Table 93. Zhejiang CONBA Pharmaceutical Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio Table 95. Zhejiang CONBA Pharmaceutical Recent Development Table 96. Henan Topfond Company Information Table 97. Henan Topfond Business Overview Table 98. Henan Topfond Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Henan Topfond Finasteride Product Portfolio Table 100. Henan Topfond Recent Development Table 101. Guangdong Eashu Pharmacetical Company Information Table 102. Guangdong Eashu Pharmacetical Business Overview Table 103. Guangdong Eashu Pharmacetical Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. Guangdong Eashu Pharmacetical Finasteride Product Portfolio Table 105. Guangdong Eashu Pharmacetical Recent Development Table 106. RelonChem Company Information Table 107. RelonChem Business Overview Table 108. RelonChem Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 109. RelonChem Finasteride Product Portfolio Table 110. RelonChem Recent Development Table 111. Dr. Reddy Company Information Table 112. Dr. Reddy Business Overview Table 113. Dr. Reddy Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 114. Dr. Reddy Finasteride Product Portfolio Table 115. Dr. Reddy Recent Development Table 116. Cipla Company Information Table 117. Cipla Business Overview Table 118. Cipla Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 119. Cipla Finasteride Product Portfolio Table 120. Cipla Recent Development Table 121. Actavis Company Information Table 122. Actavis Business Overview Table 123. Actavis Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 124. Actavis Finasteride Product Portfolio Table 125. Actavis Recent Development Table 126. Accord Pharmaceuticals Company Information Table 127. Accord Pharmaceuticals Business Overview Table 128. Accord Pharmaceuticals Finasteride Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 129. Accord Pharmaceuticals Finasteride Product Portfolio Table 130. Accord Pharmaceuticals Recent Development Table 131. North America Finasteride Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 132. North America Finasteride Sales by Country (2021-2026) & (tons) Table 133. North America Finasteride Sales Market Share by Country (2021-2026) Table 134. North America Finasteride Sales Forecast by Country (2027-2032) & (tons) Table 135. North America Finasteride Sales Market Share Forecast by Country (2027-2032) Table 136. North America Finasteride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Finasteride Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Finasteride Market Share by Country (2021-2026) Table 139. North America Finasteride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Finasteride Market Share Forecast by Country (2027-2032) Table 141. Europe Finasteride Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 142. Europe Finasteride Sales by Country (2021-2026) & (tons) Table 143. Europe Finasteride Sales Market Share by Country (2021-2026) Table 144. Europe Finasteride Sales Forecast by Country (2027-2032) & (tons) Table 145. Europe Finasteride Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Finasteride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Finasteride Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Finasteride Market Share by Country (2021-2026) Table 149. Europe Finasteride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Finasteride Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Finasteride Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Finasteride Sales by Country (2021-2026) & (tons) Table 153. Asia-Pacific Finasteride Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Finasteride Sales Forecast by Country (2027-2032) & (tons) Table 155. Asia-Pacific Finasteride Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Finasteride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Finasteride Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Finasteride Market Share by Country (2021-2026) Table 159. Asia-Pacific Finasteride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Finasteride Market Share Forecast by Country (2027-2032) Table 161. Latin America Finasteride Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 162. Latin America Finasteride Sales by Country (2021-2026) & (tons) Table 163. Latin America Finasteride Sales Market Share by Country (2021-2026) Table 164. Latin America Finasteride Sales Forecast by Country (2027-2032) & (tons) Table 165. Latin America Finasteride Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Finasteride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Finasteride Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Finasteride Market Share by Country (2021-2026) Table 169. Latin America Finasteride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Finasteride Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Finasteride Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Finasteride Sales by Country (2021-2026) & (tons) Table 173. Middle East and Africa Finasteride Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Finasteride Sales Forecast by Country (2027-2032) & (tons) Table 175. Middle East and Africa Finasteride Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Finasteride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Finasteride Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Finasteride Market Share by Country (2021-2026) Table 179. Middle East and Africa Finasteride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Finasteride Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Finasteride Distributors List Table 184. Finasteride Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Finasteride Image Figure 2. Global Finasteride Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Finasteride Market Size (2021-2032) & (US$ Million) Figure 4. Global Finasteride Sales (2021-2032) & (tons) Figure 5. 1mg Tablet Image Figure 6. Global 1mg Tablet Sales YoY Growth (2021-2032) & (tons) Figure 7. 5mg Tablet Image Figure 8. Global 5mg Tablet Sales YoY Growth (2021-2032) & (tons) Figure 9. Global Finasteride Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Finasteride Market Share by Type 2025 VS 2032 Figure 11. North America Finasteride Sales Market Share in Volume by Type in 2025 Figure 12. North America Finasteride Sales Market Share in Value by Type in 2025 Figure 13. Europe Finasteride Sales Market Share in Volume by Type in 2025 Figure 14. Europe Finasteride Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Finasteride Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Finasteride Sales Market Share in Value by Type in 2025 Figure 17. Latin America Finasteride Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Finasteride Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Finasteride Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Finasteride Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Finasteride Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Medical Uses Image Figure 24. Global Medical Uses Sales YoY Growth (2021-2032) & (tons) Figure 25. Application 2 Image Figure 26. Global Application 2 Sales YoY Growth (2021-2032) & (tons) Figure 27. Global Finasteride Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Finasteride Market Share by Application 2025 VS 2032 Figure 29. North America Finasteride Sales Market Share in Volume by Application in 2025 Figure 30. North America Finasteride Sales Market Share in Value by Application in 2025 Figure 31. Europe Finasteride Sales Market Share in Volume by Application in 2025 Figure 32. Europe Finasteride Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Finasteride Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Finasteride Sales Market Share in Value by Application in 2025 Figure 35. Latin America Finasteride Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Finasteride Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Finasteride Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Finasteride Sales Market Share in Value by Application in 2025 Figure 39. North America Finasteride Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 40. North America Finasteride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Finasteride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Finasteride Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Finasteride Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 44. Europe Finasteride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Finasteride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Finasteride Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Finasteride Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 48. Asia-Pacific Finasteride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Finasteride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Finasteride Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Finasteride Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 52. Latin America Finasteride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Finasteride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Finasteride Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Finasteride Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 56. Middle East and Africa Finasteride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Finasteride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Finasteride Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Finasteride Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Finasteride Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg Tablet
  • 5mg Tablet
Applications
  • Medical Uses
  • Application 2
Companies covered
  • Teva Pharmaceuticals
  • Sandoz
  • Shandong Renhetang Pharmaceutical
  • Merck
  • Zhejiang CONBA Pharmaceutical
  • Henan Topfond
  • Guangdong Eashu Pharmacetical
  • RelonChem
  • Dr. Reddy
  • Cipla
  • Actavis
  • Accord Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Finasteride Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Finasteride Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Finasteride Market by Type
  6. 1.3.1 1mg Tablet
  7. 1.3.2 5mg Tablet
  8. 1.4 Global Finasteride Market Size by Type
  9. 1.4.1 Global Finasteride Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Finasteride Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Finasteride Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Finasteride Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Finasteride Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Finasteride Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Finasteride Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Finasteride Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Finasteride Industry Trends
  2. 2.2 Finasteride Industry Drivers
  3. 2.3 Finasteride Industry Opportunities and Challenges
  4. 2.4 Finasteride Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Finasteride Revenue (2021-2026)
  2. 3.2 Global Top Players by Finasteride Sales (2021-2026)
  3. 3.3 Global Top Players by Finasteride Price (2021-2026)
  4. 3.4 Global Finasteride Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Finasteride Major Company Production Sites & Headquarters
  6. 3.6 Global Finasteride Company, Product Type & Application
  7. 3.7 Global Finasteride Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Finasteride Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Finasteride Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Finasteride Tier 1, Tier 2, and Tier 3
4 Finasteride Regional Status and Outlook
  1. 4.1 Global Finasteride Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Finasteride Historic Market Size by Region
  3. 4.2.1 Global Finasteride Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Finasteride Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Finasteride Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Finasteride Forecasted Market Size by Region
  7. 4.3.1 Global Finasteride Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Finasteride Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Finasteride Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Finasteride by Application
  1. 5.1 Finasteride Market by Application
  2. 5.1.1 Medical Uses
  3. 5.1.2 Application 2
  4. 5.2 Global Finasteride Market Size by Application
  5. 5.2.1 Global Finasteride Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Finasteride Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Finasteride Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Finasteride Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Finasteride Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Finasteride Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Finasteride Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Finasteride Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceuticals
  2. 6.1.1 Teva Pharmaceuticals Company Information
  3. 6.1.2 Teva Pharmaceuticals Business Overview
  4. 6.1.3 Teva Pharmaceuticals Finasteride Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceuticals Finasteride Product Portfolio
  6. 6.1.5 Teva Pharmaceuticals Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Finasteride Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Finasteride Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Shandong Renhetang Pharmaceutical
  14. 6.3.1 Shandong Renhetang Pharmaceutical Company Information
  15. 6.3.2 Shandong Renhetang Pharmaceutical Business Overview
  16. 6.3.3 Shandong Renhetang Pharmaceutical Finasteride Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shandong Renhetang Pharmaceutical Finasteride Product Portfolio
  18. 6.3.5 Shandong Renhetang Pharmaceutical Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Finasteride Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Finasteride Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Zhejiang CONBA Pharmaceutical
  26. 6.5.1 Zhejiang CONBA Pharmaceutical Company Information
  27. 6.5.2 Zhejiang CONBA Pharmaceutical Business Overview
  28. 6.5.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio
  30. 6.5.5 Zhejiang CONBA Pharmaceutical Recent Developments
  31. 6.6 Henan Topfond
  32. 6.6.1 Henan Topfond Company Information
  33. 6.6.2 Henan Topfond Business Overview
  34. 6.6.3 Henan Topfond Finasteride Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Henan Topfond Finasteride Product Portfolio
  36. 6.6.5 Henan Topfond Recent Developments
  37. 6.7 Guangdong Eashu Pharmacetical
  38. 6.7.1 Guangdong Eashu Pharmacetical Company Information
  39. 6.7.2 Guangdong Eashu Pharmacetical Business Overview
  40. 6.7.3 Guangdong Eashu Pharmacetical Finasteride Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Guangdong Eashu Pharmacetical Finasteride Product Portfolio
  42. 6.7.5 Guangdong Eashu Pharmacetical Recent Developments
  43. 6.8 RelonChem
  44. 6.8.1 RelonChem Company Information
  45. 6.8.2 RelonChem Business Overview
  46. 6.8.3 RelonChem Finasteride Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 RelonChem Finasteride Product Portfolio
  48. 6.8.5 RelonChem Recent Developments
  49. 6.9 Dr. Reddy
  50. 6.9.1 Dr. Reddy Company Information
  51. 6.9.2 Dr. Reddy Business Overview
  52. 6.9.3 Dr. Reddy Finasteride Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dr. Reddy Finasteride Product Portfolio
  54. 6.9.5 Dr. Reddy Recent Developments
  55. 6.10 Cipla
  56. 6.10.1 Cipla Company Information
  57. 6.10.2 Cipla Business Overview
  58. 6.10.3 Cipla Finasteride Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cipla Finasteride Product Portfolio
  60. 6.10.5 Cipla Recent Developments
  61. 6.11 Actavis
  62. 6.11.1 Actavis Company Information
  63. 6.11.2 Actavis Business Overview
  64. 6.11.3 Actavis Finasteride Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Actavis Finasteride Product Portfolio
  66. 6.11.5 Actavis Recent Developments
  67. 6.12 Accord Pharmaceuticals
  68. 6.12.1 Accord Pharmaceuticals Company Information
  69. 6.12.2 Accord Pharmaceuticals Business Overview
  70. 6.12.3 Accord Pharmaceuticals Finasteride Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Accord Pharmaceuticals Finasteride Product Portfolio
  72. 6.12.5 Accord Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Finasteride Sales by Country
  2. 7.1.1 North America Finasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Finasteride Sales by Country (2021-2026)
  4. 7.1.3 North America Finasteride Sales Forecast by Country (2027-2032)
  5. 7.2 North America Finasteride Market Size by Country
  6. 7.2.1 North America Finasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Finasteride Market Size by Country (2021-2026)
  8. 7.2.3 North America Finasteride Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Finasteride Sales by Country
  2. 8.1.1 Europe Finasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Finasteride Sales by Country (2021-2026)
  4. 8.1.3 Europe Finasteride Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Finasteride Market Size by Country
  6. 8.2.1 Europe Finasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Finasteride Market Size by Country (2021-2026)
  8. 8.2.3 Europe Finasteride Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Finasteride Sales by Country
  2. 9.1.1 Asia-Pacific Finasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Finasteride Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Finasteride Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Finasteride Market Size by Country
  6. 9.2.1 Asia-Pacific Finasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Finasteride Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Finasteride Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Finasteride Sales by Country
  2. 10.1.1 South America Finasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Finasteride Sales by Country (2021-2026)
  4. 10.1.3 South America Finasteride Sales Forecast by Country (2027-2032)
  5. 10.2 South America Finasteride Market Size by Country
  6. 10.2.1 South America Finasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Finasteride Market Size by Country (2021-2026)
  8. 10.2.3 South America Finasteride Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Finasteride Sales by Country
  2. 11.1.1 Middle East and Africa Finasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Finasteride Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Finasteride Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Finasteride Market Size by Country
  6. 11.2.1 Middle East and Africa Finasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Finasteride Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Finasteride Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Finasteride Value Chain Analysis
  2. 12.1.1 Finasteride Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Finasteride Production Mode & Process
  7. 12.2 Finasteride Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Finasteride Distributors
  10. 12.2.3 Finasteride Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research